Research into conolidine has triggered discovery of an opioid receptor in the body referred to as ACKR3/CXCR7. ACKR3 seems to be probably the most sought after target for conolidine, which also disregards the opposite four classical opioid receptors(3). Provided the system of action of conolidine unlike opioids which consequently https://posecin773gat6.wikicommunication.com/user